• 1
    Li LD, Lu FZ, Zhang SW, Mu R, Sun ST, Huangpu XM, Sun J, et al. Cancer Mortality Survey, 1990-1992. [in Chinese] Journal of Chinese Oncology 1996; 18:403407.
  • 2
    Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian G-S, Tu J-T, Groopman JD, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339:943946. MEDLINE
  • 3
    Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson BE, Wogan GN, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3:310. MEDLINE
  • 4
    Sun T, Chu Y. Carcinogenesis and prevention strategy of liver cancer in area of prevalence. In MakTW, TannockI, eds. Cellular and Molecular Biology of Neoplasia. New York: Alan R. Liss. 1984; 3944.
  • 5
    Wu S, Wei Y, Ku G, Liu K, Sun ZT. Study on urinary excretion of AFM1 in Beijing and Qidong people. [in Chinese] Chin J Oncol 1984; 6:163167.
  • 6
    Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427428. MEDLINE
  • 7
    Ozturk M, et al. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338:13561359. MEDLINE
  • 8
    Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B 1972; 34:187220.
  • 9
    Tsai W-Y, Jewell NP, Wang M-C. A note on the product-limit estimator under right censoring and left truncation. Biometrika 1987; 74:883886.
  • 10
    Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992; 52(Suppl):2114S2118S. MEDLINE
  • 11
    Sun T, Wu S, Wu Y, Chu Y. Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma. In: HayashiY, NagaoM, SugimuraT, TakayamaS, TomatisL, WattenbergLW, WoganGN, eds. Diet, Nutrition and Cancer. Tokyo: Japan Sci Soc Press, 1986; 225235.
  • 12
    Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:48554878. MEDLINE
  • 13
    Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tusbota A, Koida I, Arase Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective obervation of 2215 patients. J Hepatol 1998; 28:930938. MEDLINE
  • 14
    Sun C-A, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 1996; 5:173178. MEDLINE
  • 15
    London WT, Evans AA, McGlynn K, Buetow K, An P, Gao LL, Lustbader E, et al. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995; 38:155161. MEDLINE